Could skipping routine heparin be safer for heart patients?

NCT ID NCT06981624

Recruiting now Prevention Sponsor: Olivier F. Bertrand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving the blood thinner heparin only when needed, instead of routinely, can prevent radial artery occlusion after a heart catheterization procedure. Researchers will enroll 500 patients and compare rates of artery patency, bleeding, and nursing time. The goal is to see if a selective approach works just as well with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: heparin
What this could lead to: If successful, this could show that giving heparin only when needed is just as effective as routine use, potentially reducing unnecessary medication and nursing workload.
What could go wrong: This is a moderate-sized trial (500 participants) comparing two strategies, not a new drug. The results may not change standard practice if selective heparin leads to more occlusions or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RADIAL ARTERY OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arterial occlusion Arterial Occlusive Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RADIAL ARTERY OCCLUSION

Contacts and locations

Locations

IUCPQ
RECRUITING

Québec, Quebec, G1V4G5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.